09-01-2009: Genencor, a division of Danisco A/S and BRAIN AG join forces in the field of the biobased fermentative production of industrially relevant biochemicals from renewable raw materials. Genencor will use its capabilities in metabolic pathway engineering and biomanufacturing of industrial bio-products and BRAIN AG’s expertise in the fields of metagenomics and screening technologies, to pursue product targets for the chemical industry.
BRAIN will provide Genencor access to these technologies and especially to its metagenome resources of some150 million genes of yet uncultured microorganisms. Enzymes and biosynthetic pathways of interest will then be genetically engineered in microbial production strains for the production of important biochemicals.
This new collaboration expands upon the successful collaboration first established in 2004, where the two companies joined forces to develop a new enzyme product platform.